A complete application in a minute
Tailored resume and cover letter, ready to send.
Ipsen is seeking a strategic leader to serve as Vice President, Head of Medical Affairs, Neuroscience, overseeing US medical strategy across multiple assets and phases, including Phase IV studies and marketed products. The role requires directing the US medical team, aligning with global strategies, and guiding evidence dissemination.
You will lead cross-functional medical teams, collaborate with global colleagues, and manage external relationships with healthcare professionals and advocacy
Vice President, Head of Medical Affairs, Neuroscience, leading US medical strategy and operations across multiple assets, indications, and phases, including marketed products and ongoing Phase IV studies.
oversee US medical team, align US and global strategies, support business development and asset lifecycle management, manage Phase IIIb/IV studies, and collaborate on evidence dissemination, publications, and external relationships with healthcare professionals and advocacy groups. Ensure compliance with regulatory standards and review communication materials. Lead cross-functional teams across Medical, R&D, and Commercial functions, and liaise with global teams to influence asset development and lifecycle planning.
12+ years pharma experience, including 5+ within Medical Affairs focused on Neuroscience, with at least 3 years in the US market; deep expertise in neurology, toxin development, regulatory standards, and clinical trial design; advanced scientific degree (MD, PhD, PharmD, etc.); proven leadership in cross-functional medical teams; strong scientific communication skills; knowledge of North American and global regulatory, reimbursement, and clinical development processes.
Neuroscience, neurology indications (spasticity, migraine), toxin development, Phase IIIb/IV clinical studies, HEOR expertise, and experience working with top-tier scientific experts.
cross-functionally with global and US teams, external healthcare professionals, and advocacy groups.
travel approximately 35%, based in the US.